which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Kidney renal clear cell carcinoma (KIRC) is one of the most common cancers with high mortality all over the world. Many studies have proposed that genes could be used to predict prognosis in KIRC. In this study, RNA expression data from next-generation sequencing and clinical information of 523 patients downloaded from The Cancer Genome Atlas (TCGA) dataset were analyzed in order to identify the relationship between gene expression level and the prognosis of KIRC patients. A set of five genes that significantly associated with overall survival time was identified and a model containing these five genes was constructed ...
Objective. This study is aimed at using genes related to the peroxisome proliferator-activated recep...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
BackgroundThe present study aims to investigate the gene expression changes in papillary renal cell ...
BACKGROUND:The present study aims to investigate the gene expression changes in papillary renal cell...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Renal cell carcinoma (RCC), which was one of the most common malignant tumors in urinary system, had...
Background Kidney renal clear cell carcinoma (KIRC) is a type of cancer that is resistant to chemot...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Objective To investigated the expression of metabolism-related genes (MRGs) in kidney renal clear ce...
The Identification of reliable Biomarkers able to predict the outcome after nephrectomy of patients ...
The Identification of reliable Biomarkers able to predict the outcome after nephrectomy of patients ...
Purpose. To construct a survival model for predicting the prognosis of patients with kidney renal cl...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Objective. This study is aimed at using genes related to the peroxisome proliferator-activated recep...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
BackgroundThe present study aims to investigate the gene expression changes in papillary renal cell ...
BACKGROUND:The present study aims to investigate the gene expression changes in papillary renal cell...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Renal cell carcinoma (RCC), which was one of the most common malignant tumors in urinary system, had...
Background Kidney renal clear cell carcinoma (KIRC) is a type of cancer that is resistant to chemot...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Objective To investigated the expression of metabolism-related genes (MRGs) in kidney renal clear ce...
The Identification of reliable Biomarkers able to predict the outcome after nephrectomy of patients ...
The Identification of reliable Biomarkers able to predict the outcome after nephrectomy of patients ...
Purpose. To construct a survival model for predicting the prognosis of patients with kidney renal cl...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Objective. This study is aimed at using genes related to the peroxisome proliferator-activated recep...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...
Background: Currently, there are no useful biomarkers or prognostic risk markers for the diagnosis o...